IPO Listed

Alebund Pharmaceuticals (Jiangsu) IPO

HK$1.3bn raised

HKEX: 9637 · HK$22.60 cash per share

Advisers

Alebund Pharmaceuticals (Jiangsu)

Issuer

Legal adviser

Lead managers

Bookrunner
BofA Securities (as Merrill Lynch (Asia Pacific))
CITIC CLSA (as CLSA)

Other advisers

Joint sponsors
BofA Securities (as Merrill Lynch (Asia Pacific))
Issuer
Alebund Pharmaceuticals (Jiangsu)
Issuer based in
China
Listed
29 Jun 2026
Sector
Biotech
Tags
Biotech, Pharma

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.